Cargando…

25-hydroxyvitamin D, Fibroblast Growth Factor 23, and Risk of Acute Kidney Injury Over 20 Years of Follow-Up

INTRODUCTION: Low serum 25-hydroxyvitamin D levels have been identified as a risk factor for acute kidney injury (AKI) among critically ill patients. Whether low 25-hydroxyvitamin D levels are associated with long-term incidence of hospitalization with AKI in the general population is unknown. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishigami, Junichi, Grams, Morgan E., Michos, Erin D., Lutsey, Pamela L., Matsushita, Kunihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116771/ https://www.ncbi.nlm.nih.gov/pubmed/34013108 http://dx.doi.org/10.1016/j.ekir.2021.02.009

Ejemplares similares

Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study
por: Ishigami, Junichi, et al.
Publicado: (2022)

25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
por: Michos, Erin D., et al.
Publicado: (2016)

Inpatient and Outpatient Infection as a Trigger of Cardiovascular Disease: The ARIC Study
por: Cowan, Logan T., et al.
Publicado: (2018)

Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
por: Lutsey, Pamela L., et al.
Publicado: (2014)

Clinical epidemiology of infectious disease among patients with chronic kidney disease
por: Ishigami, Junichi, et al.
Publicado: (2018)

Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
por: Hamano, Takayuki, et al.
Publicado: (2013)

Correction to: Clinical epidemiology of infectious disease among patients with chronic kidney disease
por: Ishigami, Junichi, et al.
Publicado: (2019)

Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study
por: Ishigami, Junichi, et al.
Publicado: (2018)

The association of telomere length and serum 25-hydroxyvitamin D levels in US adults: the National Health and Nutrition Examination Survey
por: Mazidi, Mohsen, et al.
Publicado: (2016)

Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
por: Karandikar, Vedika M., et al.
Publicado: (2022)

Associations between endogenous sex hormones and FGF-23 among women and men in the Multi-Ethnic Study of Atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2022)

Incidence of Dementia Following Hospitalization With Infection Among Adults in the Atherosclerosis Risk in Communities (ARIC) Study Cohort
por: Bohn, Bruno, et al.
Publicado: (2023)

Serum 25-Hydroxyvitamin D Concentrations and Incidence of Age-Related Macular Degeneration: The Atherosclerosis Risk in Communities Study
por: Millen, Amy E., et al.
Publicado: (2019)

Gender, Obesity, Fat Distribution and 25-Hydroxyvitamin D
por: Guagnano, Maria Teresa, et al.
Publicado: (2023)

The Relationship of Falls With Achieved 25-Hydroxyvitamin D Levels From Vitamin D Supplementation: The STURDY Trial
por: Michos, Erin D, et al.
Publicado: (2022)

Serum 25-Hydroxyvitamin D Concentrations and Season-Specific Correlates in Japanese Adults
por: Nanri, Akiko, et al.
Publicado: (2011)

Low 25‐Hydroxyvitamin D in Primary Hyperparathyroidism: Enhanced Conversion Into 1,25‐Hydroxyvitamin D May Not Be “True” Deficiency
por: Kabadi, Udaya M
Publicado: (2020)

Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention
por: Ishigami, Junichi, et al.
Publicado: (2021)

The First Convergent Synthesis of 23,23-Difluoro-25-hydroxyvitamin D(3) and Its 24-Hydroxy Derivatives: Preliminary Assessment of Biological Activities
por: Mototani, Sayuri, et al.
Publicado: (2022)

Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation
por: Mazahery, Hajar, et al.
Publicado: (2015)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
por: Almahmoud, Mohamed Faher, et al.
Publicado: (2018)

25-Hydroxyvitamin D and Severity of Parkinson's Disease
por: Chitsaz, Ahmad, et al.
Publicado: (2013)

Circulating Fibroblast Growth Factor‐23 and the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study
por: Alonso, Alvaro, et al.
Publicado: (2014)

Serum 25‐hydroxyvitamin D and C‐reactive protein and plasma von Willebrand concentrations in 23 dogs with chronic hepatopathies
por: Ambrosini, Yoko M., et al.
Publicado: (2022)

Incident chronic kidney disease: trends in management and outcomes
por: Perkins, Robert M., et al.
Publicado: (2016)

The serum level of 25-hydroxyvitamin D for maximal suppression of parathyroid hormone in children: the relationship between 25-hydroxyvitamin D and parathyroid hormone
por: Kang, Jung In, et al.
Publicado: (2017)

Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients
por: Zhu, Yuanjie, et al.
Publicado: (2023)

Deficiency of 25-Hydroxyvitamin D and Dyslipidemia in Indian Subjects
por: Chaudhuri, Jaydip Ray, et al.
Publicado: (2013)

Mammographic density and serum 25-hydroxyvitamin D levels
por: Crew, Katherine D, et al.
Publicado: (2014)

Performance evaluation of two immunoassays for 25-hydroxyvitamin D
por: Li, Lusha, et al.
Publicado: (2016)

25-hydroxyvitamin D status in patients with alopecia areata
por: Erpolat, Seval, et al.
Publicado: (2017)

Prediagnostic serum 25-hydroxyvitamin D and melanoma risk
por: Stenehjem, Jo S., et al.
Publicado: (2020)

Analytical Performance Specifications for 25-Hydroxyvitamin D Examinations
por: Cavalier, Etienne, et al.
Publicado: (2021)

Diabetes and the risk of hospitalisation for infection: the Atherosclerosis Risk in Communities (ARIC) study
por: Fang, Michael, et al.
Publicado: (2021)

The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency
por: Zuhur, Sayid Shafi, et al.
Publicado: (2013)

Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels
por: Chailurkit, La-or, et al.
Publicado: (2016)

Association between diuretic administration before diagnosis and incidence of acute kidney injury in patients with minimal change disease: A single-center observational study
por: Shimamura, Yoshinosuke, et al.
Publicado: (2021)

Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation
por: Dusso, Adriana S
Publicado: (2011)

Short- and long-term outcomes after incident pneumonia in adults with chronic kidney disease: a time-dependent analysis from the Stockholm CREAtinine Measurement project
por: Su, Guobin, et al.
Publicado: (2019)

Low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill
por: Braun, AB, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mntibn97glkafninv6gjs9n7cg